Find 52 companies with promising cash flow potential yet trading below their fair value.
To own Moelis, you generally need to believe in its ability to convert episodic deal activity into durable advisory earnings while managing a high-cost, talent-driven model. The Q2 2026 earnings lift, steady US$0.65 dividend, and completed buyback support the near term appeal of shareholder returns, but do little to reduce the core risks of earnings volatility from deal cycles and rising compensation and expansion costs.
Among the latest announcements, the completion of the US$72.89 million repurchase of 1,192,448 shares stands out, especially when set beside the higher quarterly net income. For investors focused on catalysts, this pairing of profitability and capital return reinforces Moelis’s current emphasis on rewarding shareholders, even as the firm continues to invest in new hires and capabilities that could pressure margins if revenue growth is uneven.
Yet against this backdrop of higher income, buybacks, and dividends, there is still a material risk investors should be aware of if deal activity slows and...
Read the full narrative on Moelis (it's free!)
Moelis' narrative projects $2.4 billion revenue and $351.6 million earnings by 2029.
Uncover how Moelis' forecasts yield a $71.00 fair value, a 7% upside to its current price.
Some of the most optimistic analysts were expecting Moelis to reach about US$2.6 billion in revenue and US$320.2 million in earnings, which is far more upbeat than consensus and could be challenged or reinforced as new results and capital return moves like the latest buyback feed into very different views of Moelis’s future.
Explore 3 other fair value estimates on Moelis - why the stock might be worth just $71.00!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com